Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS)

Circulation

Volumn 96, Issue 2, 1997, Pages 429-435

  Aengevaeren, Wim R M ^a   Uijen, Gerard J H ^b   Jukema, J Wouter ^a   Bruschke, Albert V G ^a   Van Der Werf, Tjeerd ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b University Hospital Nijmegen ^*

Author keywords

Angiography; Coronary disease; Exercise; Lipids; Perfusion

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; DOUBLE BLIND PROCEDURE; EXERCISE TEST; HEART MUSCLE PERFUSION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030806978     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.2.429     Document Type: Article

References (31)

1. Badimon JJ, Fuster V, Chesebro, Badimon L. Coronary atherosclerosis: a multifactorial disease. Circulation. 1993;87(suppl II):II-3-II-16.
2. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 383-389.
3. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis H, Deboer LWV, Mahrer PR, Masteller MJ, Vailas LI, Alaupovic P, Hirsch LJ, for the MARS Research Group. Coronary angiographic changes with lovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med. 1993;119:969-976.
4. Waters D, Higginson L, Gladstone P, Kimball B, Le May M, Boccuzzi SJ, Lesperance J, for the CCAIT Study Group. Effects of monotherapy with an HMG CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: the Canadian Coronary Atherosclerosis Intervention Trial. Circulation. 1994;89:959-968.
5. MAAS Investigators. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet. 1994;344: 633-638. (Erratum. Lancet. 1994;344:762).
6. Pitt B, Mancini GB, Ellis SG, Rosman HS, Park JS, McGovern ME. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events: PLAC I investigation. J Am Coll Cardiol. 1995;26:1133-1139.
7. Jukema JW, Bruschke AVG, van Boven AJ, Reiber JHC, Bal ET, Zwinderman AH, Jansen H, Boerma GJM, van Rappart FM, Lie KI, for the REGRESS Study Group. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: the Regression Growth Evaluation Statin Study (REGRESS). Circulation. 1995;91:2528-2540.
8. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993; 87:1781-1791.
9. Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation. 1990;81:1586-1593.
10. Zeiher AM, Drexler H, Sauerbier B, Just H. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension: endothelium-mediated coronary flow modulation in humans. J Clin Invest. 1993; 92:652-662.
11. Gilligan DM, Guetta V, Panza JA, García CE, Quyyumi AA, Cannon RO. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation. 1994;90:35-41.
12. Berdeaux A, Ghaleh B, Dubois-Randé JL, Vigué B, Drieu la Rochelle C, Hittinger L, Giudicelli JF. Role of vascular endothelium in exercise-induced dilation of large epicardial coronary arteries in conscious dogs. Circulation. 1994;89:2799-2808.
13. Kroon AA, Stalenhoef AFH, Buikema H, Demacker PNM, de Wilde PCM, Leijten PA, van Gilst WH. The effect of cholesterol reduction on endothelial function and progression of atherosclerosis in WHHL rabbits. Atherosclerosis. 1993;103:221-230.
14. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A. Reduction of serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 1994;89:2519-2524.
15. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995;332:481-487.
16. Pijls NHJ, Uijen GJH, Hoevelaken A, Arts T, Aengevaeren WRM, Bos HS, Fast JH, van Leeuwen KL, van der Werf T. Mean transit time for assessment of myocardial perfusion by videodensitometry. Circulation. 1990;81:1331-1340.
17. Pijls NHJ, Aengevaeren WRM, Uijen GJH, Hoevelaken A, Pijnenburg T, van Leeuwen K, van der Werf T. Concept of maximal flow ratio for immediate evaluation of percutaneous transluminal coronary angioplasty result by videodensitometry. Circulation. 1991; 83:854-865.
18. Pijls NHJ, Uijen GJH, Pijnenburg T, van Leeuwen K, Aengevaeren WRM, Barth JD, den Arend J, Hoevelaken A, van der Werf T. Reproducibility of the mean transit time for maximal myocardial flow assessment by videodensitometry. Int J Card Imaging. 1991;6: 101-108.
19. Aengevaeren WRM, Kroon AA, Stalenhoef AFH, Uijen GJH, van der Werf T. Low density lipoprotein-apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease: the LDL-Apheresis Atherosclerosis Regression Study (LAARS). J Am Coll Cardiol. 1996;28: 1696-1704.
20. Campeau L. Grading of angina pectoris. Circulation. 1976;54: 522-523.
21. Uren NG, Marraccini P, Gistri R, de Silva R, Camici PG. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol. 1993;22:650-658.
22. Schühlen H, Eigler HL, Whiting JS. Digital angiographic impulse response analysis of regional myocardial perfusion: detection of autoregulatory changes in nonstenotic coronary arteries induced by collateral flow to adjacent stenotic arteries. Circulation. 1994;89: 1004-1012.
23. Cox DA, Vita JA, Treasure CB, Fish D, Alexander RW, Ganz P, Selwyn AP. Atherosclerosis impairs flow-mediated dilatation of coronary arteries in humans. Circulation. 1989;80:458-465.
24. Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease: a potential noninvasive marker of healing coronary endothelium. Circulation. 1994;89:1530-1538.
25. Schuler G, Hambrecht R, Schlierf G, Niebauer J, Hauer K, Neumann J, Hoberg E, Drinkmann A, Bacher F, Grunze M, Kübler W. Regular physical exercise and low-fat diet: effects on progression of coronary artery disease. Circulation. 1992;86:1-11.
26. Schuler G, Hambrecht R, Schlierf G, Grunze M, Methfessel S, Hauer K, Kübler W. Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol. 1992;19:34-42.
27. Gould KL, Ornish D, Scherwitz L, Brown S, Edens RP, Hess MJ, Mullani N, Bolomey L, Dobbs F, Armstrong WT, Merritt T, Ports T, Sparler S, Billings J. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995;274:894-901.
28. Eichstädt HW, Eskötter H, Hoffman I, Amthauer HW, Weidinger G. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. Am J Cardiol. 1995;76: 122A-125A.
29. Fawcett JP, Menkes DB. Does cholesterol depletion have adverse effects on blood rheology? Angiology. 1994;45:199-206.
30. Tsuda Y, Satoh K, Takahashi T, Kitadai M, Ichihara S, Ayada Y, Hosomi N, Kawanishi K, Sada, Yamamoto M. Effect of medication with pravastatin sodium on hemorheological parameters in patients with hyperlipoproteinemia. Int Angiol. 1993;12:360-364.
31. Mcdowell IF, Smye M, Trinick T, Shortt JA, Archibald MP, Trimble ER, Nichols DP. Simvastatin in severe hypercholesterolaemia: a placebo controlled trial. Br J Clin Pharmacol. 1991;31:340-343.